AusBiotech

AusBiotech and Ernst & Young will again host the ‘Australian Life Science Investment Showcase’ in New York, prior to America’s pre-eminent biotechnology industry conference, BIO 2012 in Boston. The Showcase will give investors an overview of Australia’s top companies with emerging therapeutics in one invitation-only meeting. Date: Friday 15 June 2012 (prior to BIO2012 convention in Boston) Contact: Hayley Laing, Investment Program Manager

AusBiotech is managing the Australian pavilion at BIO 2012. The 2012 BIO International Convention, June 18 - 21, 2012 is the global event for biotechnology that hosts more than 125 sessions, an exhibition with more than 1,800 companies and 60 pavilions and a business forum with 14,000 One-on-One partnering sessions. With nearly 60 countries represented, the attendees are a blend of international and domestic executives and management from research, business, and academic and investment communities.

An information and training event has been organised especially for sponsors and manufacturers of medical devices and in vitro diagnostic medical devices at Old Parliament House in Canberra on Friday 22 June 2012 from 9:30am to 4:20pm. The event has been organised by the Regulatory and Technical Consultative Forum to help all sponsors and manufacturers better understand the regulation of medical technology. The members of the Consultative Forum are: · The Therapeutic Goods Administration (TGA) · Medical Technology Association of Australia · IVD Australia · The Australian Dental Industry Association · AusBiotech · The Association of Therapeutic Goods Consultants. Speakers from the TGA will be addressing topics identified by the industry associations and the TGA that have practical application to help companies improve their everyday business dealings with the regulator. Sessions will cover a wide range of regulatory issues relating to submitting applications, post marketing surveillance and adverse event reporting, The program consists of sessions relevant for people who are relatively new to the medical technology industry, advanced sessions for more experienced people and sessions especially developed for IVD sponsors and manufacturers. CONTACT: Cliff Spong at MTAA (cspong@mtaa.org.au) Peter Harman at IVD Australia (p.harman@ivd.org.au) Troy Williams at ADIA (troy.williams@adia.org.au) Julie Chmielowski at AusBiotech (juliec@ausbiotech.org)

AusBiotech, in conjunction with LES invites you to our next local event. This event will have a medical device theme with speakers and topics being confirmed shortly. Contact: Kirsty Grimwade

Agricultural biotechnology offers some of the best prospects for an ecologically sustainable future and an assured food supply. Agbiotech researchers and industry leaders will gather at ABIC 2012 to discuss diverse applications of the technology, from new sources of energy and new materials for industry and consumers, to high quality agricultural products, biosecurity and conservation.

Information available June 2012, please contact Hayley Laing with any questions or queries or to express your interest. Date: Wednesday 3 October 2012 Contact: Hayley Laing, Investment Program Manager

Information available June 2012, please contact Hayley Laing with any questions or queries or to express your interest. Date: Friday 5 October 2012 Contact: Hayley Laing, Investment Program Manager

The AusBiotech national conference is the premier biotechnology and life sciences conference for the Australia and Asia-Pacific Region, attracting more than 1,200 participants from throughout the Asia-Pacific region, the USA and Europe. Appealing to CEOs, MDs, Executive and Senior Managers of global biotechnology and pharmaceutical companies; Biotechnologists; Venture Capitalists; Researchers; Entrepreneurs; Manufacturers; Media Professionals; Legal, Financial and other Service Providers; Patent Attorneys and Licensing Professionals the program will feature business commercialization, emerging technologies and human health presentations from the best in the world.

The Australasian Life Science Investment Summit 2012, is again a major satellite event connected to Australia’s pre-eminent biotechnology industry conference, AusBiotech 2012, and will be held at the Melbourne Convention & Exhibition Centre on Friday 2 November 2012. Last year's summit attracted over 120 investors from around the world to showcase the 40 most promising Australian biotechnology companies actively seeking capital or partnering opportunities. The audience featured an excellent mix of expertise from national and international investors, including angel investors, venture capitalists, fund managers, investment bankers and representatives from superannuation funds. The audience also included venture capital arms of the major pharmaceutical companies from Australia, Asia Pacific, North America and Europe. Presenting companies will be a mix of listed companies in late-stage development, private companies with identified product/opportunities and early-stage commercialisation companies from research institutes and universities. Date: Friday 2 November (part of the AusBiotech 2012 conference) Contact: Hayley Laing, Investment Program Manager

AusBiotech is managing the Australian pavilion at MEDICA 2012. MEDICA is recognised, both nationally and internationally, as the pre-eminent event for the health and medical industry. MEDICA 2011 attracted 4,571 international exhibitors and 134,500 delegates from 100 countries and all continents. Held annually in Düsseldorf, Germany, MEDICA is the meeting point for general practitioners, hospital doctors, hospital managers, hospital nursing staff, hospital technical managers, medical trade, medical industry, medical assistants, laboratory managers and physiotherapists.